Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity - Editorial comment

被引：42
|
作者：
Chancellor, MB [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 02期
关键词：
Bladder; neurogenic; Botulinum toxins; Drug resistance;
D O I：
10.1097/01.ju.0000108407.53880.6a
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：804 / 805
页数：2
相关论文
共 50 条
  • [1] Effect of botulinum toxin type A on idiopathic and neurogenic detrusor overactivity
    Leskovar, Jurij
    Hajdinjak, Tine
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (06): : 475 - 481
  • [2] Editorial Comment to Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin
    Truzzi, Jose C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (12) : 1165 - 1166
  • [3] Botulinum toxin type?A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients
    Hikita, Katsuya
    Honda, Masashi
    Kawamoto, Bunya
    Panagiota, Tsounapi
    Inoue, Seiya
    Hinata, Nobuyuki
    Muraoka, Kuniyasu
    Takenaka, Atsushi
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (01) : 94 - 99
  • [4] Intradetrusor injection with botulinum toxin type A in the treatment of neurogenic.. detrusor overactivity: our experience
    Balado Lopez, A. M.
    Vazquez Guimaraens, M.
    Montoto Marques, A.
    Ferreiro Velasco, M. E.
    Salvador de la Barrera, S.
    Rodriguez Sotillo, A.
    Sanchez Rodriguez-Losada, J.
    PROCEEDINGS OF THE 18TH EUROPEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE (PRM), 2012, : 48 - 50
  • [5] Botulinum Toxin in Neurogenic Detrusor Overactivity
    Levi D'Ancona, Carlos Arturo
    Ferreira, Ruiter Silva
    Rassi, Mauricio Carneiro
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2012, 16 (03) : 139 - 143
  • [6] Botulinum neurotoxin type A in neurogenic detrusor overactivity
    Boethig, R.
    Kaufmann, A.
    Bremer, J.
    Pannek, J.
    Domurath, B.
    UROLOGE, 2014, 53 (04): : 524 - 530
  • [7] ENDOSCOPIC INTRADETRUSOREAL BOTULINUM TOXIN TYPE A (BTX-A) INJECTION FOR THE MANAGEMENT OF NEUROGENIC DETRUSOR OVERACTIVITY (NDO). TECHNIQUE DEMONSTRATION
    Konstantinidis, Charalampos
    Ploumidis, Achileas
    Kalokerinou, Kyriaki
    Skriapas, Konstantinos
    Rapidi, Christina Anastasia
    Karyotis, Ioanis
    Delakas, Dimitrios
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A527 - A527
  • [8] Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice
    Knuepfer, Stephanie
    Juenemann, Klaus-Peter
    THERAPEUTIC ADVANCES IN UROLOGY, 2014, 6 (01) : 34 - 42
  • [9] INJECTION OF BOTULINUM TOXIN TYPE A AS A THERAPEUTIC OPTION FOR BLADDER PRESERVATION IN PATIENTS WITH SEVERE NEUROGENIC DETRUSOR OVERACTIVITY
    Williams, Taisha
    Beck, M. E.
    Lehrfeld, T. J.
    Serio, J.
    Nguyen, T.
    Gordon, D. A.
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 252 - 252
  • [10] Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity
    Jousain, Charles
    Phe, Veronique
    Even, Alexia
    Chartier-Kastler, Emmanuel
    Denys, Pierre
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2017, 53 (06) : 991 - 997
12345